• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

50.3400 USD 0.0800 0.16%

As of 16:00:00 ET on 11/25/2014.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 50.6800 High - Low: 50.6800 - 49.9374 Primary Exchange: NYSE Arca
Volume: 79,957 52-Week Range: 35.1200 - 51.0700 Beta vs DZOTR: 1.0003

ETF Chart for PBE

No chart data available.
  • PBE:US 50.3300
  • 1D
  • 1M
  • 1Y
50.4200
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD / MICHAEL JEANETTE
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2014-11-24) 50.3958
Assets (M) (on 2014-11-24) 438.4430
Shares out (M) 8.70
Market Cap (M) 437.61
% Premium 0.05
Average 52-Week % Premium 0.0084
Fund Leveraged N

Dividends for PBE

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.0429
Dividend Yield (ttm) 0.55%

Performance for PBE

1-Month +3.34% 1-Year +36.68%
3-Month +10.45% 3-Year +40.42%
Year To Date +36.93% 5-Year +25.61%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 11/24/2014
Name Position Value % of Total
Sigma-Aldrich Corp 197,314 26,978,743 6.152%
Amgen Inc 147,228 24,171,893 5.512%
Regeneron Pharmaceuticals Inc 58,542 23,987,585 5.470%
Alexion Pharmaceuticals Inc 121,215 23,533,892 5.367%
Pharmacyclics Inc 164,970 23,143,641 5.278%
Illumina Inc 114,409 21,870,424 4.987%
Gilead Sciences Inc 190,747 19,189,148 4.376%
Biogen Idec Inc 59,821 18,349,494 4.185%
Isis Pharmaceuticals Inc 274,609 14,395,004 3.283%
Medivation Inc 122,651 13,709,929 3.126%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil